Abnormal expression of CPEB3 has been found in a variety of cancers, such as cervical cancer and human hepatocellular carcinoma [26]; studies have found that miRNAs can directly target the CPEB3/EGFR axis to regulate tumor progression, but few studies are focusing on the nervous system. This evidence concerns the gene CPEB3 and hepatocellular carcinoma.